Yang, L B <br/><br/>
Deficiency of complement defense protein CD59 may contribute to neurodegeneration in Alzheimer's disease.  [electronic resource] 

 -  The Journal of neuroscience : the official journal of the Society for Neuroscience  Oct 2000 
 - 7505-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1529-2401 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Alzheimer Disease--immunology<br/>Amyloid beta-Peptides--pharmacology<br/>CD59 Antigens--genetics<br/>Cell Differentiation--drug effects<br/>Cell Survival--drug effects<br/>Cells, Cultured<br/>Complement C9--genetics<br/>Complement System Proteins--pharmacology<br/>Dose-Response Relationship, Drug<br/>Female<br/>Frontal Lobe--metabolism<br/>Gene Expression--drug effects<br/>Glycosylphosphatidylinositols--metabolism<br/>Hippocampus--metabolism<br/>Humans<br/>Male<br/>Neurons--drug effects<br/>Peptide Fragments--pharmacology<br/>Phosphatidylinositol Diacylglycerol-Lyase<br/>Phosphopyruvate Hydratase--metabolism<br/>RNA, Messenger--metabolism<br/>Ribonucleases--deficiency<br/>Synaptophysin--metabolism<br/>Transfection<br/>Type C Phospholipases--antagonists & inhibitors